Texier Thomas 4
4 · Marex Group plc · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Marex (MRX) Group Head Thomas Texier Sells 14,427 Shares
What Happened
Thomas Texier, Group Head of Clearing at Marex Group plc (MRX), sold a total of 14,427 ordinary shares in open-market transactions on April 1, 2026. The sale consisted of 9,589 shares at a weighted-average price of $43.28 (proceeds $414,968) and 4,838 shares at a weighted-average price of $43.97 (proceeds $212,748), for combined gross proceeds of approximately $627,716. These were sales (not purchases) and are typically considered routine dispositions.
Key Details
- Transaction date: 2026-04-01; Form 4 filed: 2026-04-02 (timely filing).
- Sales reported:
- 9,589 shares sold at a weighted-average price of $43.28 — proceeds $414,968 (prices in this block ranged $42.77 to $43.7650).
- 4,838 shares sold at a weighted-average price of $43.97 — proceeds $212,748 (prices in this block ranged $43.77 to $44.32).
- Footnotes of note:
- Sale executed pursuant to a Rule 10b5‑1 trading plan adopted Sept 10, 2025 (pre‑set plan for scheduled trading).
- Weighted-average prices cover a range of transaction prices; the filer offers to provide per-price sale counts on request.
- Filing notes 192,348 shares underlying deferred bonus awards are included in the reported beneficial ownership figures (these are contingent awards).
- Shares owned after the transaction: not specified in this filing beyond the note about 192,348 deferred-award shares.
Context
- The sales were made under a 10b5‑1 plan, which means they were pre-authorized trades executed according to a schedule or criteria set earlier; such sales are often considered routine and do not necessarily signal a change in insider sentiment.
- For retail investors, purchases by insiders are generally more informative about insider confidence; routine plan-based sales are common for diversification, liquidity, or tax planning.
Insider Transaction Report
Form 4
Texier Thomas
Group Head of Clearing
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-04-01$43.28/sh−9,589$414,968→ 247,496 total - Sale
Ordinary Shares
[F1][F3][F4]2026-04-01$43.97/sh−4,838$212,748→ 242,658 total
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $42.77 to $43.7650 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $43.77 to $44.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The number of ordinary shares reported herein includes 192,348 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Signature
/s/ Scott Linsley as Attorney-in-Fact, for Thomas Texier|2026-04-02